![]() | Only 14 pages are availabe for public view |
Abstract The aim of the current study was to test the ability of orally administered Thymoquinone to inhibit OPMDs ―oral leukoplakia‖ progression into frank malignancy through modulation of molecular cancer biomarkers in patients with potentially malantign oral leukoplakia |